CAPTRUST Financial Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-419,721
| Closed | -$4.14M | – | 2570 |
|
|
2023
Q4 | $4.14M | Buy |
419,721
+6,407
| +2% | +$63.2K | 0.01% | 615 |
|
|
2023
Q3 | $3.16M | Buy |
+413,314
| New | +$3.16M | 0.01% | 679 |
|
|
2022
Q2 | – | Sell |
-161
| Closed | -$1K | – | 5109 |
|
|
2022
Q1 | $1K | Buy |
161
+141
| +705% | +$876 | ﹤0.01% | 4739 |
|
|
2021
Q4 | $0 | Buy |
+20
| New | – | ﹤0.01% | 4891 |
|